Attached files
| file | filename |
|---|---|
| EX-3.1 - EXHIBIT 3.1 - IONIS PHARMACEUTICALS INC | ex3_1.htm |
| EX-3.2 - EXHIBIT 3.2 - IONIS PHARMACEUTICALS INC | ex3_2.htm |
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): December 18, 2015
IONIS PHARMACEUTICALS, INC.
(Exact Name of Registrant as Specified in Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
|
000-19125
|
33-0336973
|
|
|
(Commission File No.)
|
(IRS Employer Identification No.)
|
2855 Gazelle Court
Carlsbad, CA 92010
(Address of Principal Executive Offices and Zip Code)
Registrant’s telephone number, including area code: (760) 931-9200
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 5.03. | Amendment to Articles of Incorporation or Bylaws; Fiscal Year. |
Effective December 18, 2015, the Company changed its name from “Isis Pharmaceuticals, Inc.” to “Ionis Pharmaceuticals, Inc.” by filing a certificate of amendment (“Certificate of Amendment”) to its Restated Certificate of Incorporation with the Secretary of State of the State of Delaware. The Company also amended and restated its bylaws to reflect the change to the Company’s name, effective December 18, 2015. The Certificate of Amendment and amended and restated bylaws are attached hereto as Exhibit 3.1 and Exhibit 3.2, respectively, and are incorporated herein by reference.
In connection with the name change, the Company will trade on the NASDAQ Global Select Market under the new ticker symbol “IONS”. The new ticker symbol will become effective at the open of the market on December 22, 2015.
| Item 9.01. | Financial Statements and Exhibits. |
| (d) | Exhibits. |
|
3.1
|
Certificate of Amendment to the Company’s Restated Certificate of Incorporation, filed December 18, 2015.
|
|
|
3.2
|
Amended and Restated Bylaws
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
Ionis Pharmaceuticals, Inc.
|
||
|
Dated: December 18, 2015
|
By:
|
/s/ B. Lynne Parshall
|
|
B. Lynne Parshall
|
||
|
Chief Operating Officer
|
||
INDEX TO EXHIBITS
|
Certificate of Amendment to the Company’s Restated Certificate of Incorporation, filed December 18, 2015.
|
||
|
Amended and Restated Bylaws
|